2024 annual financial data
Protara Therapeutics 2024 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -49,154,000 USD and net income was -44,596,000 USD.
Operating cash flow was -35,808,000 USD.
Get free Protara Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -49,154,000 USD
- Net income
- -44,596,000 USD
- Operating cash flow
- -35,808,000 USD